Application 212515
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212515-001 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | AB2 | 1 | 3f0d92c62455… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | XLCare Pharmaceuticals Inc. | add6afb8-d38c-47a2-8c35-d5940667bb0c | 2024-12-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | a84c1eab-5934-4e5d-8bb2-0734d6adba6a | 2024-10-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | 1580ab76-e229-4b8d-8c7b-82f39fecfebd | 2024-10-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | A-S Medication Solutions | b2d163aa-1056-47dd-85aa-297800e6c772 | 2024-10-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | A-S Medication Solutions | 00cbc656-768d-4995-bb6d-a0d4b32a248c | 2024-10-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Advanced Rx of Tennessee, LLC | 248a4705-1403-e94a-e063-6294a90a3544 | 2024-10-15 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | f2e8821e-04c9-4812-8c9e-39340775cc6e | 2024-09-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Limited | 741102c1-8809-44d4-9098-3dc8c0604764 | 2024-09-05 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Solco Healthcare US, LLC | 9489b635-385e-4a05-be02-df39fcafebe3 | 2024-08-27 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 85ed0cbc-df84-44df-a9eb-f9587dbc21df | 2024-08-21 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Bryant Ranch Prepack | ff3c7dd3-2dcc-498c-a121-1e2aa62c7a97 | 2024-08-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Zydus Lifesciences Limited | 6c1c3a1f-80a4-417c-8830-5edbb9a0710f | 2024-08-12 | Tadalafil TADALAFIL | |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 185a3284-3a4f-44d3-9278-98581d33f95b | 2024-08-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Proficient Rx LP | 929e391e-b74b-4ccd-8690-16ffcece7a30 | 2024-08-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 9f83ea2e-8ee8-ab6d-e053-2995a90a1e96 | 2024-06-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | a0acad71-8ae3-2827-e053-2995a90a20b3 | 2024-06-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aurobindo Pharma Limited | a0ecc7cf-20dd-485a-b4dd-1bbc587280a7 | 2024-06-03 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aurobindo Pharma Limited | 0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 | 2024-05-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | a73b0e6f-09fc-42d6-a678-1409ce746bd1 | 2024-05-17 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Asclemed USA, Inc. | 101f44e4-669c-4e3d-843a-a27157750f9c | 2024-05-07 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.